Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Warning Letters

Warning Letters

                        About Warning and Close-Out Letters Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Compliance Actions and Activities
          Warning Letters
          Marion Mullet Farm - 665227 - 11/28/2023Warning Letters WARNING LETTER
      Marion Mullet Farm
            
      MARCS-CMS 665227 —           November 28, 2023


    
Share
    Post
    Linkedin

    Email
    PrintDelivery Method: 
        VIA UPS
      
      
              Product: 
        Animal & VeterinaryFood & Beverages            


Recipient:

                      Recipient Name
              Mr. Marion E. Mullet
                                Recipient Title
              Owner
          
            Marion Mullet Farm

          
                      61584 County Road 33Goshen, IN 46528-6513United States            

       Issuing Office:
        
         
          Division of Human and Animal Food Operations East VI
        
         
          United StatesSecondary Issuing Offices
          United States

 

 

**WARNING LETTER
CMS 665227**

November 28, 2023
Dear Mr. Mullet:

On June 9, 2023 and June 22, 2023, a representative of the U.S. Food and Drug Administration conducted an inspection of your calf dealer located at 61584 County Road 33, Goshen, IN. This letter notifies you of violations of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) that were revealed during our inspection of your operation. You can find the FD&C Act and its associated regulations on the Internet through links on the FDA’s web page at www.fda.gov.

At the close of the inspection, you were issued a form FDA 483, Inspectional Observations (FDA 483). We have not received a response to the FDA 483 as of the date of this letter.

**Adulteration of an Animal Offered for Human Consumption**

Our inspection found that you hold animals under conditions that are inadequate such that medicated animals bearing potentially harmful drug residues are likely to enter the food supply because you failed to maintain complete and accurate treatment records. Specifically, you do not maintain any treatment records for drugs administered to calves on your farm. Food held under conditions whereby it may have been rendered injurious to health is adulterated.***1***

**Adulteration of a New Animal Drug**

Our inspection found that you adulterated Sulfamethoxazole and Trimethoprim Tablets (**(b)(4)**), by administering this drug contrary to the prescription from your veterinarian. The prescription by your veterinarian was to use this drug for the treatment and prevention of diarrhea (scours), pneumonia, & ear infection by administering **(b)(4)** tablets every **(b)(4)** with a **(b)(4)** meat withdrawal period. During the inspection, you stated that you administer **(b)(4)** tablets orally to most calves based on how they look when you purchase them and that you are not concerned about meat withdrawal periods because you inform buyers that calves might be medicated. Use of a drug in a manner not consistent with its labeling is extralabel use. The extra-label use of approved animal or human drugs in animals is allowed under the FD&C Act only if the extra-label use complies with sections 512(a)(4) and (5) of the FD&C Act (21 U.S.C. §§ 360b(a)(4) and (5)), and 21 CFR § 530, including that the use must be by or on the lawful order of a licensed veterinarian within the context of a valid veterinarian/client/patient relationship as defined by 21 CFR § 530.3(i)(1). Your use of this drug was not in conformance with its approved labeling and did not comply with 21 CFR 530 because you did not follow your veterinarian’s prescription. You therefore caused the drug to be unsafe and adulterated.***2***

**Conclusion**

This letter is not intended to be an all-inclusive statement of violations that may exist at your facility. You are responsible for investigating and determining the causes of any violations and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of federal law and FDA regulations.

This letter notifies you of our concerns and provides you an opportunity to address them. Failure to adequately address this matter may lead to legal action, including without limitation, seizure and injunction.

Within fifteen (15) working days of receipt of this letter, please notify this office in writing of the specific steps that you have taken to correct any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation. If you cannot complete corrective actions within fifteen (15) working days, state the reason for the delay and the time frame within which you will complete the correction. If you believe that you have complied with the FD&C Act and FDA regulations, include your reasoning and any supporting information for our consideration.

Your written response should be sent to Dylan C. Grippi, Compliance Officer, at 300 River Place Drive, Suite 5900, Detroit, MI 48207 or via email (preferred) to Dylan.Grippi@fda.hhs.gov. If you have any questions about this letter, please contact Mr. Grippi at (301) 452-1608, or by e-mail at Dylan.Grippi@fda.hhs.gov.

Sincerely,
/S/

William R. Weissinger, MS
Program Division Director
Office of Human and Animal Food Operations East Division 6

CC: **(b)(4)**

________________________

***1*** See section 402(a)(4) of the FD&C Act [21 U.S.C. § 342(a)(4)]

***2*** Under section 501(a)(5) of the FD&C Act [21 U.S.C. § 351(a)(5)], a new animal drug is deemed adulterated if it is unsafe within the meaning of section 512 of the FD&C Act [21 U.S.C. § 360b].

                                                                                  Content current as of:
      01/30/2024
               
                
Regulated Product(s)
		 Animal & Veterinary
			  			     			  			     Food & BeveragesMore Warning Letters

     
    Warning Letters

          
                        About Warning and Close-Out Letters
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop